β-Estradiol 6-(O-carboxymethyl)oxime: BSA
SIGMA/E5630
MDL Number: MFCD03613560
Product Type: Chemical
| extent of labeling | ~30 mol steroid per mol BSA |
| form | lyophilized powder |
| Quality Level | 200 ![]() |
| shipped in | ambient |
| solubility | phosphate buffer: 0.90-1.10 mg/mL, faintly hazy to hazy, colorless to faintly yellow |
| sterility | non-sterile |
| storage temp. | 2-8°C |
| Application: | β-Estradiol 6-(O-carboxymethyl)oxime: BSA has been used: • to test its effect on the N-methyl- • to coat microplates for the detection of plasma 17β-Estradiol levels using indirect enzyme-linked immunosorbent assay (ELISA) • to test its effect on MutL homolog 1 in colorectal cancer lines |
| Biochem/physiol Actions: | β-Estradiol 6-(O-carboxymethyl)oxime: BSA mimics estrogen and favors amyloid precursor protein α (sAPPα) secretion in vitro studies with primary rat cortical neurons. It also stimulates mitogen-activated protein kinase (MAPK) activity in human umbilical vein endothelial cells |
| General description: | β-Estradiol 6-(O-carboxymethyl)oxime: BSA is an estradiol conjugate and is membrane-impermeable. BSA is linked to the estradiol at position 6 to form the β-estradiol 6-(O-carboxymethyl) oxime: BSA conjugate. |
| Packaging: | 5, 10, 25 mg in glass bottle |
| Symbol | ![]() GHS07,GHS08 |
| Signal word | Warning |
| Hazard statements | H302 + H312 + H332 - H351 |
| Precautionary statements | P201 - P280 - P301 + P312 - P302 + P352 + P312 - P304 + P340 + P312 - P308 + P313 |
| Hazard Codes | Xn |
| Risk Statements | 20/21/22-40 |
| Safety Statements | 22-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | 2-8°C |
| UNSPSC | 51111800 |



